INTERVIEW: Epigenomics remains optimistic of colon cancer blood test approval chances
This article was originally published in Clinica
Executive Summary
Epigenomics is hopeful of getting US FDA approval for its Epi proColon colorectal cancer blood test in the next few weeks, following “constructive discussions” with the agency.